Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals. METHODS: Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease (CVD) from 39 highest-ranking hospitals in 10 Chinese cities. RESULTS: Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022) patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%, among patients with coronary heart disease without ischemic stroke was 59.2%. CONCLUSION: Statin is underused in secondary prevention among patients with atherosclerotic CVD in China. There is a large gap between guideline recommended statin use and in practice. Thus, it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.

Type

Journal article

Journal

Zhonghua Xin Xue Guan Bing Za Zhi

Publication Date

05/2011

Volume

39

Pages

397 - 401

Keywords

Aged, Arteriosclerosis, Cardiovascular Diseases, Cerebrovascular Disorders, China, Drug Utilization, Female, Hospitals, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Male, Middle Aged, Secondary Prevention